<?xml version="1.0" encoding="ISO-8859-1"?>

<rss version="2.0">
<channel>
<title>Bioiberica - PRWeb Press Release Group</title>
<link>http://www.rsspad.com/rss2/22161.xml</link>
<description>Bioiberica - Powered by PRWeb and RSSPad</description>
<language>en</language>
<managingEditor>xml@emediawire.com</managingEditor>
<webMaster>xml@emediawire.com</webMaster>
<ttl>30</ttl>
<item>
         <title>Bioiberica Announces the Osteoarthritis And Synovitis Symposium</title>
         <link>http://www.prweb.com/releases/2007/12/prweb574195.htm</link><description>   <![CDATA[ <P>New effects of chondroitin sulfate December 7th 2007, in ft. Lauderdale. (PRWeb Dec 5, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/12/prweb574195.htm">http://www.prweb.com/releases/2007/12/prweb574195.htm</a></P>]]>
                </description>
<pubDate>Wed, 05 Dec 2007 08:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2007/12/prweb574195.htm</guid> </item>
<item>
         <title>Bioiberica: Advances in the Treatment of Synovitis Chondroitin Sulfate Shows Significant Promise </title>
         <link>http://www.prweb.com/releases/osteoarthritis/synovitis/prweb566602.htm</link><description>   <![CDATA[ <P>Bioiberica is instrumental in investigating the link between synovitis and osteoarthritis (OA). In their compilation of study data it has been concluded that synovitis may be present from the onset of the OA pathology and this may contribute to the worsening of chondral lesions. (PRWeb Nov 5, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/osteoarthritis/synovitis/prweb566602.htm">http://www.prweb.com/releases/osteoarthritis/synovitis/prweb566602.htm</a></P>]]>
                </description>
<pubDate>Mon, 05 Nov 2007 08:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/osteoarthritis/synovitis/prweb566602.htm</guid> </item>
<item>
         <title>Bioiberica: Supporting Role of Dietary Supplements as Disease-Modifying Osteoarthritis Drugs</title>
         <link>http://www.prweb.com/releases/Bioiberica/CS__GLU/prweb565958.htm</link><description>   <![CDATA[ <P><a href="http://www.csbioactive.com/" onclick="linkClick( this.href );"  target="_blank" title="Bioiberica">Bioiberica</a> supports the growing body of evidence that clinically proves the effect of chondroitin sulfate (CS) and glucosamine (GLU) in slowing the progression of osteoarthritis (OA). (PRWeb Nov 1, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/Bioiberica/CS__GLU/prweb565958.htm">http://www.prweb.com/releases/Bioiberica/CS__GLU/prweb565958.htm</a></P>]]>
                </description>
<pubDate>Thu, 01 Nov 2007 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/Bioiberica/CS__GLU/prweb565958.htm</guid> </item>
<item>
         <title>Bioiberica Osteoarthritis Update: International Rheumatology Societies Give Chondroitin Sulphate The Maximum Level Of Recommendation</title>
         <link>http://www.prweb.com/releases/2007/10/prweb565190.htm</link><description>   <![CDATA[ <P>Bioiberica highlights two 2007 research studies recommending the use of chondroitin sulfate (CS) as first treatment option for osteoarthritis (OA). (PRWeb Oct 30, 2007)</P>
                                <P>Read the full story at <a href="http://www.prweb.com/releases/2007/10/prweb565190.htm">http://www.prweb.com/releases/2007/10/prweb565190.htm</a></P>]]>
                </description>
<pubDate>Tue, 30 Oct 2007 07:00:00 GMT</pubDate><guid isPermaLink="true">http://www.prweb.com/releases/2007/10/prweb565190.htm</guid> </item>
</channel>
</rss>